🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Hepatitis A Vaccine (Inactivated)

Found 0 matching trials

Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C Infection

PHASE2

The GI-5005 therapeutic vaccine in combination with standard of care or sta...

Status

Completed

Location

University of Alabama Birmingham

Start Date

2007-12

Trial ID

NCT00606086

Treatments Being Tested

GI-5005 Pegylated Interferon and Ribavirin

Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED)

PHASE3

The purpose of this study is to evaluate the safety, tolerability, and immu...

Status

Completed

Location

Multiple Locations

Start Date

2002-03

Trial ID

NCT00092469

Treatments Being Tested

V441, diptheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis B (recombinant), & Haemophilus influenza type b conjugate vaccine

Safety and Immunogenicity Evaluation After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants and Toddlers

PHASE3

The primary immunogenicity objective is to assess and compare the immunogen...

Status

Completed

Location

Site 22

Start Date

2008-03

Trial ID

NCT00667602

Treatments Being Tested

MenACWY-CRM197 (two doses)MenC PCV7 DTPa-IPV-HepB-Hib MenACWY-CRM197 (one dose)

Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants

PHASE3

The purpose of this trial is to clinically confirm that the manufacturing p...

Status

Completed

Location

Multiple Locations

Start Date

2006-11

Trial ID

NCT00404651

Treatments Being Tested

DTaP-IPV-HB-PRP~T vaccine DTaP-IPV-HB-PRP~T vaccine DTaP-IPV-HB-PRP~T vaccine DTaP-HBV-IPV vaccine

Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule

PHASE3

To demonstrate that the immune response to hepatitis B antigen of the DTaP-...

Status

Completed

Location

Multiple Locations

Start Date

2006-07

Trial ID

NCT00315055

Treatments Being Tested

DTaP-IPV-HB-PRP~T vaccine DTaP-IPV//PRP~T combined Hepatitis B vaccine

Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months

PHASE3

This is a study to evaluate the immune response and safety of GSK Biologica...

Status

Completed

Location

GSK Investigational Site

Start Date

2003-11-11

Trial ID

NCT00197236

Treatments Being Tested

Havrix™Infanrix™ActHIB™

Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children

PHASE2

Safety: To describe the safety profiles following vaccination. Immunogeni...

Status

Completed

Location

Multiple Locations

Start Date

2008-03

Trial ID

NCT00621764

Treatments Being Tested

Japanese encephalitis vaccine (Day 0) Hepatitis A vaccine (Day 28)Hepatitis A vaccine (Day 0) Japanese encephalitis vaccine (Day 28)Japanese encephalitis vaccine (Day 0) Hepatitis A vaccine (Day 28)Hepatitis A vaccine (Day 0) Japanese encephalitis vaccine (Day 28)

Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age

PHASE3

This is a study to evaluate the immunogenicity and safety of GSK Biological...

Status

Completed

Location

GSK Investigational Site

Start Date

2003-09-11

Trial ID

NCT00197002

Treatments Being Tested

GSK Biologicals 2-dose inactivated hepatitis A vaccine (Havrix)Prevnar™

Immunogenicity of a Live Attenuated Chimeric JE Vaccine (IMOJEV) as a Booster Dose in Thai Children Primed With CD.JEVAX

PHASE4

This study was undertaken to assess the immunogenicity and safety of a boos...

Status

Completed

Location

Multiple Locations

Start Date

2014-06

Trial ID

NCT02526550

Treatments Being Tested

Live attenuated chimeric Japanese Encephalitis vaccine Inactivated Hepatitis A vaccine

Phase IV Study of Concomitant Administration of the sIPV and HepA

PHASE4

This study is a randomized, open-labeled phase IV clinical trial to evaluat...

Status

Not Yet Recruiting

Location

Jiu Longpo District Center for Disease Control and Disease

Start Date

2024-06-15

Trial ID

NCT06460545

Treatments Being Tested

sIPV (booster dose at 18 months of age)HepA-L HepA-I

Previous Next